Abstract: An article having an anti-contamination surface, including a substrate; a first region present on a portion of a surface of the substrate and having a lubricating layer formed thereon; and a second region present on at least a portion of a surface of the substrate other than the first region and having an anti-adhesion coating layer formed thereon; and a method for forming an anti-contamination surface on the surface of an article.

Abstract: The present invention relates to hybrid exosomes, a use of the same, and a preparation method of the same, and the hybrid exosomes provided from the present invention have excellent skin inflammation amelioration, skin wrinkle amelioration, skin moisturization efficacy, and skin regeneration efficacy compared to using hydrangea-derived exosomes and liposomes alone, and thus can be effectively utilized as a cosmetic composition containing the same as an active ingredient. In addition, the hybrid exosomes have better stability and biocompatibility compared to existing exosomes.

Abstract: The present invention relates to a multi-stage decellularized mammal-derived tissue matrix, prepared by a method comprising: a preparation step for preparing tissue of a non-human mammal; a pretreatment step for pretreating the tissue; a first inactivation step for inactivating a virus included in the pretreated tissue using alcohol; a primary decellularization step for removing cells from the virus-inactivated tissue using an aqueous basic solution; a secondary decellularization step for removing cells by enzymatically treating the primary decellularized tissue; and a second inactivation step for inactivating a virus included in the decellularized tissue using an acid, and wherein the DNA content in the tissue subjected to the second inactivation step is 50 ng/mg or less, and the reduction rate (L) of the elastin content in the tissue subjected to the pretreatment step to the second inactivation step is 20% or less; and a method for preparing the same.

Abstract: The present invention relates to a multi-stage decellularized mammal-derived tissue supplement, prepared by a method comprising: a preparation step for preparing tissue of a non-human mammal; a pretreatment step for pretreating the tissue; a first inactivation step for inactivating a virus included in the pretreated tissue using alcohol; a primary decellularization step for removing cells from the virus-inactivated tissue using an aqueous basic solution; a secondary decellularization step for removing cells by enzymatically treating the primary decellularized tissue; and a second inactivation step for inactivating a virus included in the decellularized tissue using an acid, and wherein the DNA content in the tissue subjected to the pretreatment step to the second inactivation step is 50 ng/mg or less, and the degradation time using 100 U/ml of collagenase is at least 90 hours; and a method for preparing the same.

Abstract: A muscular strength assisting apparatus includes a muscular strength assisting portion that assists a user's muscular strength and a first connecting link including one side connected to one side of the muscular strength assisting portion and an opposite side rotatable relative to a shoulder of the user about a first rotation axis. The muscular strength assisting portion includes an upper arm module that assists muscular strength of an upper arm of the user and a link assembly including one side connected to one side of the upper arm module to be rotatable about a second rotation axis non-parallel to the first rotation axis and an opposite side disposed adjacent to a portion of a body of the user to be supported on the user.

Abstract: The present invention relates to an antibody against resistin and use thereof and, more specifically, to a resistin antibody or antigen-binding fragment thereof that inhibits the activity of resistin by blocking resistin/CAP1 binding, a nucleic acid encoding same, a vector comprising the nucleic acid, a cell transformed with the vector, a method for preparing the antibody or antigen-binding fragment thereof, an antibody-drug conjugate comprising the antibody or antigen-binding fragment thereof, a bi- or multi-specific antibody, a chimeric antigen receptor, an immune cell containing same, and a composition for the prevention or treatment of diseases that can be treated through the inhibition of resistin activity, the composition comprising same.

Abstract: Disclosed herein is an image shake correcting module. The image shake correcting module includes an optical module, a first holder, a first drive unit, a second holder, a second drive unit, a third holder, a housing, an outer cover, and a substrate. The optical module may be mounted in an inner space of the first holder. The first drive unit may include a first drive ball, a first magnet and a first coil for primary driving of the first holder. The first holder may be mounted in an inner space of the second holder. The second drive unit may include a second drive ball, a second magnet, and a second coil for secondary driving of the second holder. The second holder may be mounted in an inner space of the third holder. The third holder may be mounted in an inner space of the housing.

Abstract: The present invention relates to a method for producing a spheroid including neurons and astrocytes, the method including: culturing induced pluripotent stem cell-neural progenitor cells (iPSC-NPCs) in an NPC medium; culturing the cultured cells in a neuronal differentiation medium (NDM); and culturing the cultured cells in a glial differentiation medium (GDM). The spheroid produced by the method according to the present invention contains mature neurons and astrocytes which express a desired marker after 3 weeks of in vitro culture and has a uniform size, and thus can be used for simple visual screening to confirm drug efficacy.

Abstract: A signal transmitting method suitable for a MU-MIMO environment and achieving a high performance with low complexity is provided. The signal transmitting method includes: splitting each message stream into a common message stream and a private message stream; combining a plurality of common message streams for the plurality of receivers to generate a common stream; encoding the common stream and private message streams for the plurality of receivers to generate an encoded common stream and encoded private message streams; precoding the encoded common stream and the encoded private message streams to adjust amplitudes and phases of symbols such that power is distributed between the encoded common stream and the encoded private message streams and generate precoded signals; and converting the precoded signals into a plurality of RF signals, adjusting phases of the plurality of RF signals, and outputting the phase-adjusted RF signals through a plurality of MIMO antennas.

Abstract: Discussed is a solar cell including a semiconductor substrate having an inclined part; first and second conductivity type regions formed at or on one surface of the semiconductor substrate; a first electrode connected to the first conductivity type region on the one surface of the semiconductor substrate; and a second electrode connected to the second conductivity type region on the one surface of the semiconductor substrate. At least one of the first and second electrodes includes a finger part including a plurality of inner finger parts extending in a first direction, and a plurality of outer finger parts extending in the first direction adjacent to an edge of the semiconductor substrate; and a connection part connecting at least some of the plurality of outer finger parts on one side of the semiconductor substrate adjacent to the inclined part.

Abstract: Discussed is a solar cell including a semiconductor substrate, a conductive region disposed in the semiconductor substrate or over the semiconductor substrate, and an electrode electrically connected to the conductive region. The electrode includes a first electrode part and a second electrode part disposed over the first electrode part. The second electrode part includes a particle connection layer formed by connecting a plurality of particles including a first metal and a cover layer including a second metal different from the first metal and covering at least the outside surface of the particle connection layer.

Abstract: An aramid fabric having excellent adhesion to a polyurethane matrix resin and excellent tensile strength is produced by the method including the steps of: (i) weaving a basket-structured aramid fabric by using aramid yarns as warp and weft yarns; and then (ii) dipping the woven aramid fabric in a sizing agent solution consisting of an aqueous polyurethane resin as a sizing agent and water, followed by squeezing and drying. In the present disclosure, the sizing agent is applied to the woven aramid fabric, thereby effectively preventing the deterioration in weaving efficiency. Further, the aramid fabric is woven in a basket weave, and thus the compactness of the aramid fabric is lowered and the wetting property of the aramid fabric with the polyurethane matrix resin is improved.

Abstract: The present invention relates to bacterial ghosts, and more particularly, to a method of preparing bacterial ghosts from gram-positive bacteria by hydrochloric acid treatment. Specifically, according to the present invention, when gram-positive bacteria were cultured after being treated with a minimum inhibitory concentration (MIC) of hydrochloric acid capable of inhibiting colony formation of gram-positive bacteria, bacterial ghosts were effectively formed. Since the formed bacterial ghosts have no intracellular proteins or DNA while preserving cell wall integrity, the risk of side effects such as secondary infection caused by bacterial growth when the bacterial ghosts are administered to humans is low. Therefore, the bacterial ghosts prepared from gram-positive bacteria according to the method of the present invention may be effectively used as a vaccine or a foreign antigen carrier for preventing or treating gram-positive bacterial infection.

Abstract: Discussed is a solar cell including a semiconductor substrate having an inclined part; first and second conductivity type regions formed at or on one surface of the semiconductor substrate; a first electrode connected to the first conductivity type region on the one surface of the semiconductor substrate; and a second electrode connected to the second conductivity type region on the one surface of the semiconductor substrate. At least one of the first and second electrodes includes a finger part including a plurality of inner finger parts extending in a first direction, and a plurality of outer finger parts extending in the first direction adjacent to an edge of the semiconductor substrate; and a connection part connecting at least some of the plurality of outer finger parts on one side of the semiconductor substrate adjacent to the inclined part.

Abstract: An aramid fabric having excellent adhesion to a polyurethane matrix resin and excellent tensile strength is produced by the method including the steps of: (i) weaving a basket-structured aramid fabric by using aramid yarns as warp and weft yarns; and then (ii) dipping the woven aramid fabric in a sizing agent solution consisting of an aqueous polyurethane resin as a sizing agent and water, followed by squeezing and drying. In the present disclosure, the sizing agent is applied to the woven aramid fabric, thereby effectively preventing the deterioration in weaving efficiency. Further, the aramid fabric is woven in a basket weave, and thus the compactness of the aramid fabric is lowered and the wetting property of the aramid fabric with the polyurethane matrix resin is improved.

Abstract: Discussed is a solar cell including a semiconductor substrate, a conductive region disposed in the semiconductor substrate or over the semiconductor substrate, and an electrode electrically connected to the conductive region. The electrode includes a first electrode part and a second electrode part disposed over the first electrode part. The second electrode part includes a particle connection layer formed by connecting a plurality of particles including a first metal and a cover layer including a second metal different from the first metal and covering at least the outside surface of the particle connection layer.

Abstract: An aramid yarn which is adhesive to a polyurethane matrix resin is disclosed. The polyurethane resin is adhered and impregnated to the surface and inside of the aramid yarn, and the content of the polyurethane resin is 1.5 to 7.0% by weight based on the sum of the weight of the polyurethane resin adhered and impregnated to the surface and inside of the aramid yarn plus the weight of the aramid yarn before the polyurethane resin is adhered and impregnated. An aramid fabric is woven into a basket-weave structure and thus has low denseness, the wetting property with the polyurethane matrix resin which is impregnated into the aramid fabric is improved, and consequently, the adhesive properties between the aramid fabric and the polyurethane matrix resin are improved.

Abstract: The present specification relates to an artificial manipulation or modification in an expression regulatory gene of an over-amplified repeated sequence. More specifically, a system for regulating the expression of an over-amplified repeated sequence including an artificially manipulated gene to reduce the expression of the over-amplified repeated sequence. The artificially manipulated gene includes one or more genes selected from the group consisting of an SPT4 gene, SPT5 gene, SUPT4H gene, and SUPT5H gene. The artificially manipulated gene includes an artificial mutation in a genomic sequence of the gene. The artificially manipulated gene includes a gene whose function is impaired or has reduced expression.

Abstract: The present invention provides a pharmaceutical formulation comprising clomipramine or its pharmaceutically acceptable salt (preferably, clomipramine hydrochloride) as the first active ingredient, and sildenafil or its pharmaceutically acceptable salt (preferably, sildenafil citrate) as the second active ingredient, wherein stability of clomipramine is improved, and a method for manufacturing this pharmaceutical formulation. In particular, the present invention provides a pharmaceutical formulation comprising the above two active ingredients and manufactured by using a wet granulation method, wherein stability of clomipramine is improved, and a method for manufacturing this pharmaceutical formulation.

Abstract: The present invention relates to a pharmaceutical composition for treating, preventing or improving premature ejaculation, which is taken on demand prior to sexual activity, the composition comprising clomipramine hydrochloride in an amount of 14 to 16 mg, preferably about 15 mg, as an active ingredient. More preferably, the composition of the present invention further comprises pregelatinized starch and sodium starch glycolate. The pharmaceutical composition of the present invention can provide rapid onset of efficacy, reduce a dissolution (absorption) deviation according to the patient's gastrointestinal pH conditions and minimize side effects.